Pars Plana Vitrectomy Clinical Trial
Official title:
Suprachoroidal Hemorrhage Associated With Pars Plana Vitrectomy
NCT number | NCT05013281 |
Other study ID # | TR2021SCH |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2010 |
Est. completion date | January 28, 2021 |
Verified date | July 2021 |
Source | Beijing Tongren Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV).
Status | Completed |
Enrollment | 28 |
Est. completion date | January 28, 2021 |
Est. primary completion date | June 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Suprachoroidal hemorrhage associated with pars plana vitrectomy Exclusion Criteria: - Patients with eye trauma-related Suprachoroidal hemorrhage were excluded. |
Country | Name | City | State |
---|---|---|---|
China | Beijing Tongren Hospital | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing Tongren Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | pathogenesis | pathogenesis of PPV-related SCH and incidence of PPV-related SCH | baseline | |
Secondary | vision acuity | the final vision acuity | up to 7 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05990829 -
Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial
|
Phase 4 | |
Recruiting |
NCT05631054 -
Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients
|
||
Recruiting |
NCT05728476 -
Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema
|
N/A | |
Recruiting |
NCT04774146 -
Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy
|
||
Completed |
NCT04278079 -
Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
|
N/A | |
Not yet recruiting |
NCT05592912 -
Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities
|
Phase 1 | |
Completed |
NCT00548197 -
Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
|
Phase 1 | |
Terminated |
NCT00936520 -
SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy
|
Phase 1 | |
Recruiting |
NCT05248334 -
A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy
|
Phase 1 |